Conformational dynamics of Kir3.1/Kir3.2 channel activation via δ-opioid receptors

Molecular Pharmacology

Volumn 83, Issue 2, 2013, Pages 416-428

  Richard Lalonde, Melissa ^a,b   Nagi, Karim ^a,b   Audet, Nicolas ^a,b   Sleno, Rory ^d   Amraei, Mohammad ^g   Hogue, Mireille ^c   Balboni, Gianfranco ^f   Schiller, Peter W ^e   Bouvier, Michel ^c   Hébert, Terence E ^d   Pineyro, Graciela ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL KIR3.1; INWARDLY RECTIFYING POTASSIUM CHANNEL KIR3.2; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL STRAIN HEK293; CHANNEL GATING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; LIGAND BINDING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION;

BINDING SITES; CELL LINE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HEK293 CELLS; HUMANS; KINETICS; LIGANDS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN SUBUNITS; RECEPTORS, OPIOID, DELTA;

EID: 84872723984     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.081950     Document Type: Article

References (42)

1. Audet N, Charfi I, Mnie-Filali O, Amraei M, Chabot-Doré AJ, Millecamps M, Stone LS, and Pineyro G (2012) Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists. J Neurosci 32:4827-4840.
2. Audet N, Galés C, Archer-Lahlou E, Vallières M, Schiller PW, Bouvier M, and Pineyro G (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283: 15078-15088.
3. Audet N and Piñeyro G (2011) Using BRET to detect ligand-specific conformational changes in preformed signalling complexes. Methods Mol Biol 756:149-163.
4. Berchiche YA, Gravel S, Pelletier ME, St-Onge G, and Heveker N (2011) Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization. Mol Pharmacol 79: 488-498.
5. Berlin S, Keren-Raifman T, Castel R, Rubinstein M, Dessauer CW, Ivanina T, and Dascal N (2010) G alpha(i) and G betagamma jointly regulate the conformations of a G betagamma effector, the neuronal G protein-activated K+ channel (GIRK). J Biol Chem 285:6179-6185.
6. Berlin S, Tsemakhovich VA, Castel R, Ivanina T, Dessauer CW, Keren-Raifman T, and Dascal N (2011) Two distinct aspects of coupling between Ga(i) protein and G protein-activated K+ channel (GIRK) revealed by fluorescently labeled Ga(i3) protein subunits. J Biol Chem 286:33223-33235.
7. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, and Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301.
8. Breit A, Gagnidze K, Devi LA, Lagacé M, and Bouvier M (2006) Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Mol Pharmacol 70: 686-696.
9. Clancy SM, Fowler CE, Finley M, Suen KF, Arrabit C, Berton F, Kosaza T, Casey PJ, and Slesinger PA (2005) Pertussis-toxin-sensitive Galpha subunits selectively bind to C-terminal domain of neuronal GIRK channels: evidence for a heterotrimeric G-protein-channel complex. Mol Cell Neurosci 28:375-389.
10. David M, Richer M, Mamarbachi AM, Villeneuve LR, Dupré DJ, and Hebert TE (2006) Interactions between GABA-B1 receptors and Kir 3 inwardly rectifying potassium channels. Cell Signal 18:2172-2181.
11. Finley M, Arrabit C, Fowler C, Suen KF, and Slesinger PA (2004) betaL-betaM loop in the C-terminal domain of G protein-activated inwardly rectifying K(+) channels is important for G(betagamma) subunit activation. J Physiol 555:643-657.
12. Ford CE, Skiba NP, and Bae H, et al. (1998) Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280:1271-1274.
13. Fowler CE, Aryal P, Suen KF, and Slesinger PA (2007) Evidence for association of GABA(B) receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins. J Physiol 580:51-65.
14. Galés C, Rebois RV, Hogue M, Trieu P, Breit A, Hébert TE, and Bouvier M (2005) Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2:177-184.
15. He C, Yan X, Zhang H, Mirshahi T, Jin T, Huang A, and Logothetis DE (2002) Identification of critical residues controlling G protein-gated inwardly rectifying K (+) channel activity through interactions with the beta gamma subunits of G proteins. J Biol Chem 277:6088-6096.
16. He C, Zhang H, Mirshahi T, and Logothetis DE (1999) Identification of a potassium channel site that interacts with G protein betagamma subunits to mediate agonist-induced signaling. J Biol Chem 274:12517-12524.
17. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, and Kurachi Y (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90:291-366.
18. Huang CL, Jan YN, and Jan LY (1997) Binding of the G protein betagamma subunit to multiple regions of G protein-gated inward-rectifying K+ channels. FEBS Lett 405:291-298.
19. Huang CL, Slesinger PA, Casey PJ, Jan YN, and Jan LY (1995) Evidence that direct binding of G beta gamma to the GIRK1 G protein-gated inwardly rectifying K+ channel is important for channel activation. Neuron 15:1133-1143.
20. Ivanina T, Rishal I, Varon D, Mullner C, Frohnwieser-Steinecke B, Schreibmayer W, Dessauer CW, and Dascal N (2003) Mapping the Gbetagamma-binding sites in GIRK1 and GIRK2 subunits of the G protein-activated K+ channel. J Biol Chem 278:29174-29183.
21. Lavine N, Ethier N, Oak JN, Pei L, Liu F, Trieu P, Rebois RV, Bouvier M, Hebert TE, and Van Tol HH (2002) G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J Biol Chem 277: 46010-46019.
22. Logothetis DE, Kurachi Y, Galper J, Neer EJ, and Clapham DE (1987) The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325:321-326.
23. Lüscher C and Slesinger PA (2010) Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11: 301-315.
24. Ma D, Zerangue N, Raab-Graham K, Fried SR, Jan YN, and Jan LY (2002) Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 33:715-729.
25. Marker CL, Cintora SC, Roman MI, Stoffel M, and Wickman K (2002) Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice. Neuroreport 13:2509-2513.
26. Mase Y, Yokogawa M, Osawa M, and Shimada I (2012) Structural basis for modulation of gating property of G protein-gated inwardly rectifying potassium ion channel (GIRK) by i/o-family G protein α subunit (Gαi/o). J Biol Chem 287: 19537-19549.
27. Mercier JF, Salahpour A, Angers S, Breit A, and Bouvier M (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931.
28. Peleg S, Varon D, Ivanina T, Dessauer CW, and Dascal N (2002) G(alpha)(i) controls the gating of the G protein-activated K(+) channel, GIRK. Neuron 33:87-99.
29. Piñeyro G (2009) Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling. Cell Signal 21:179-185.
30. Piñeyro G, Azzi M, De Léan A, Schiller P, and Bouvier M (2001) Short-term inverseagonist treatment induces reciprocal changes in delta-opioid agonist and inverseagonist binding capacity. Mol Pharmacol 60:816-827.
31. Piñeyro G, Azzi M, deLéan A, Schiller PW, and Bouvier M (2005) Reciprocal regulation of agonist and inverse agonist signaling efficacy upon short-term treatment of the human delta-opioid receptor with an inverse agonist. Mol Pharmacol 67: 336-348.
32. Rasmussen SG, DeVree BT, and Zou Y et al. (2011) Crystal structure of the b2 adrenergic receptor-Gs protein complex. Nature 477:549-555.
33. Rebois RV, Robitaille M, Galés C, Dupré DJ, Baragli A, Trieu P, Ethier N, Bouvier M, and Hébert TE (2006) Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. J Cell Sci 119:2807-2818.
34. Riven I, Iwanir S, and Reuveny E (2006) GIRK channel activation involves a local rearrangement of a preformed G protein channel complex. Neuron 51:561-573.
35. Robitaille M, Ramakrishnan N, Baragli A, and Hébert TE (2009) Intracellular trafficking and assembly of specific Kir3 channel/G protein complexes. Cell Signal 21: 488-501.
36. Rubinstein M, Peleg S, Berlin S, Brass D, Keren-Raifman T, Dessauer CW, Ivanina T, and Dascal N (2009) Divergent regulation of GIRK1 and GIRK2 subunits of the neuronal G protein gated K+ channel by GalphaiGDP and Gbetagamma. J Physiol 587:3473-3491.
37. Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, and Chung NN (1999) The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists. Biopolymers 51:411-425.
38. Smrcka AV, Lehmann DM, and Dessal AL (2008) G protein betagamma subunits as targets for small molecule therapeutic development. Comb Chem High Throughput Screen 11:382-395.
39. Vergura R, Balboni G, and Spagnolo B et al. (2008) Anxiolytic- and antidepressantlike activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29:93-103.
40. Westfield GH, Rasmussen SG, and Su M et al. (2011) Structural flexibility of the G alpha s alpha-helical domain in the beta2-adrenoceptor Gs complex. Proc Natl Acad Sci USA 108:16086-16091.
41. Yokogawa M, Osawa M, Takeuchi K, Mase Y, and Shimada I (2011) NMR analyses of the Gbetagamma binding and conformational rearrangements of the cytoplasmic pore of G protein-activated inwardly rectifying potassium channel 1 (GIRK1). J Biol Chem 286:2215-2223.
42. Zhang JH, Chung TD, and Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4:67-73.